IMP
Process View
sprouting angiogenesis
The extension of new blood vessels from existing capillaries into avascular tissues resulting from the proliferation of blood vessel endothelial cells.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "sprouting angiogenesis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| VEGFA | vascular endothelial growth factor A | 1.000 | ||
| TEK | TEK tyrosine kinase, endothelial | 1.000 | ||
| JAG1 | jagged 1 | 1.000 | Human | |
| FGFR2 | fibroblast growth factor receptor 2 | 1.000 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | Zebrafish Mouse | |
| NOTCH1 | notch 1 | 0.999 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.990 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.987 | Mouse | |
| NOTCH3 | notch 3 | 0.986 | Human | |
| E2F7 | E2F transcription factor 7 | 0.986 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.982 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.979 | ||
| ILK | integrin-linked kinase | 0.977 | ||
| NRP1 | neuropilin 1 | 0.971 | Mouse | |
| FGFR1 | fibroblast growth factor receptor 1 | 0.965 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.960 | Human | |
| E2F8 | E2F transcription factor 8 | 0.942 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.931 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.922 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.892 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.887 | ||
| CTGF | connective tissue growth factor | 0.857 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.839 | ||
| ENG | endoglin | 0.838 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.825 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.825 | ||
| ZNF746 | zinc finger protein 746 | 0.824 | ||
| FN1 | fibronectin 1 | 0.812 | Zebrafish | |
| LCK | lymphocyte-specific protein tyrosine kinase | 0.809 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.789 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.789 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.756 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.735 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.702 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.686 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.621 | ||
| THBS1 | thrombospondin 1 | 0.617 | ||
| ANGPT2 | angiopoietin 2 | 0.607 | Human | |
| EGR2 | early growth response 2 | 0.587 | Human | |
| EGR1 | early growth response 1 | 0.582 | Human | |
| HSPG2 | heparan sulfate proteoglycan 2 | 0.521 | ||
| EFNA1 | ephrin-A1 | 0.516 | ||
| CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) | 0.508 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.496 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.482 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.471 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.467 | ||
| VEGFC | vascular endothelial growth factor C | 0.464 | Human | |
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.459 | ||
| PGF | placental growth factor | 0.458 | Human Rat | |
| GDF9 | growth differentiation factor 9 | 0.456 | ||
| HMOX2 | heme oxygenase (decycling) 2 | 0.445 | ||
| MEF2C | myocyte enhancer factor 2C | 0.430 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.420 | ||
| FLNA | filamin A, alpha | 0.393 | ||
| NCK2 | NCK adaptor protein 2 | 0.392 | ||
| FGA | fibrinogen alpha chain | 0.385 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.372 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.346 | Human | |
| COL4A2 | collagen, type IV, alpha 2 | 0.310 | ||
| EGR3 | early growth response 3 | 0.308 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.296 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.294 | ||
| FSTL1 | follistatin-like 1 | 0.289 | ||
| CD63 | CD63 molecule | 0.280 | ||
| BCL6 | B-cell CLL/lymphoma 6 | 0.274 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.271 | ||
| EGFL7 | EGF-like-domain, multiple 7 | 0.258 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.258 | ||
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.242 | ||
| HDAC3 | histone deacetylase 3 | 0.227 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.225 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.225 | Human | |
| TGFB2 | transforming growth factor, beta 2 | 0.225 | ||
| FBN1 | fibrillin 1 | 0.219 | ||
| BTRC | beta-transducin repeat containing | 0.219 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.207 | ||
| DSG2 | desmoglein 2 | 0.203 | ||
| FBLN1 | fibulin 1 | 0.202 | ||
| JAG2 | jagged 2 | 0.199 | Human | |
| CD34 | CD34 molecule | 0.198 | ||
| MYOCD | myocardin | 0.193 | ||
| FBLN5 | fibulin 5 | 0.190 | ||
| MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 0.185 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.184 | Human | |
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.180 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.175 | ||
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide | 0.169 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.158 | ||
| IL8 | interleukin 8 | 0.155 | ||
| ANGPT1 | angiopoietin 1 | 0.151 | ||
| DSP | desmoplakin | 0.144 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.142 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.138 | Mouse | |
| TCF4 | transcription factor 4 | 0.138 | ||
| CPE | carboxypeptidase E | 0.137 | ||
| STX5 | syntaxin 5 | 0.134 | ||
| LAMA4 | laminin, alpha 4 | 0.130 | ||
| EPHA3 | EPH receptor A3 | 0.126 | Human | |
| STC1 | stanniocalcin 1 | 0.120 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.119 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.119 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.117 | Zebrafish Mouse | |
| MAML1 | mastermind-like 1 (Drosophila) | 0.116 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.114 | ||
| NRP2 | neuropilin 2 | 0.113 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.108 | ||
| KLF6 | Kruppel-like factor 6 | 0.108 | Human | |
| NOTCH2 | notch 2 | 0.106 | Human | |
| PLXDC1 | plexin domain containing 1 | 0.105 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.105 | ||
| NOTCH4 | notch 4 | 0.101 | Human | |
| ANGPTL2 | angiopoietin-like 2 | 0.099 | Human | |
| DPP4 | dipeptidyl-peptidase 4 | 0.097 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.096 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.096 | ||
| SH3BP2 | SH3-domain binding protein 2 | 0.093 | ||
| FGF10 | fibroblast growth factor 10 | 0.093 | Human | |
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.091 | ||
| FGF2 | fibroblast growth factor 2 (basic) | 0.089 | ||
| EFNB2 | ephrin-B2 | 0.086 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.086 | Human | |
| BGN | biglycan | 0.084 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.084 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.084 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.083 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.082 | ||
| U2AF1 | U2 small nuclear RNA auxiliary factor 1 | 0.081 | ||
| FGG | fibrinogen gamma chain | 0.079 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.079 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.079 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.078 | ||
| LTA | lymphotoxin alpha (TNF superfamily, member 1) | 0.077 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.077 | Human | |
| SPG21 | spastic paraplegia 21 (autosomal recessive, Mast syndrome) | 0.075 | ||
| VCAN | versican | 0.075 | ||
| TMSB10 | thymosin beta 10 | 0.074 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.074 | ||
| THBD | thrombomodulin | 0.073 | ||
| DPT | dermatopontin | 0.073 | ||
| GEM | GTP binding protein overexpressed in skeletal muscle | 0.072 | ||
| SIK1 | salt-inducible kinase 1 | 0.072 | ||
| THBS2 | thrombospondin 2 | 0.067 | Human | |
| TLN1 | talin 1 | 0.066 | ||
| PRRX1 | paired related homeobox 1 | 0.066 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.065 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.065 | Zebrafish | |
| NFATC1 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | 0.064 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.063 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.061 | ||
| GFI1B | growth factor independent 1B transcription repressor | 0.061 | ||
| ZCCHC17 | zinc finger, CCHC domain containing 17 | 0.061 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.060 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.059 | Human | |
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.058 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.058 | ||
| EMP3 | epithelial membrane protein 3 | 0.058 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.057 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.057 | ||
| GPC1 | glypican 1 | 0.057 | ||
| LDLR | low density lipoprotein receptor | 0.057 | ||
| PDGFC | platelet derived growth factor C | 0.056 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.056 | ||
| ATN1 | atrophin 1 | 0.055 | ||
| CDH3 | cadherin 3, type 1, P-cadherin (placental) | 0.055 | Human | |
| DCN | decorin | 0.055 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.054 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.054 | Human | |
| TNC | tenascin C | 0.054 | ||
| S100A4 | S100 calcium binding protein A4 | 0.052 | ||
| YAP1 | Yes-associated protein 1 | 0.051 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.050 | ||
| PRKD2 | protein kinase D2 | 0.050 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.048 | ||
| TBX2 | T-box 2 | 0.048 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.048 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.048 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.047 | Rat | |
| FHL2 | four and a half LIM domains 2 | 0.047 | ||
| LOX | lysyl oxidase | 0.046 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.046 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.046 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.046 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.045 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.045 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.044 | Human | |
| ADAMTS2 | ADAM metallopeptidase with thrombospondin type 1 motif, 2 | 0.043 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.043 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.043 | ||
| ZNF331 | zinc finger protein 331 | 0.042 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.041 | ||
| ERRFI1 | ERBB receptor feedback inhibitor 1 | 0.040 | ||
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.040 | ||
| FST | follistatin | 0.040 | ||
| ASRGL1 | asparaginase like 1 | 0.039 | ||
| WASL | Wiskott-Aldrich syndrome-like | 0.039 | ||
| ITGA2B | integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | 0.039 | ||
| DOCK1 | dedicator of cytokinesis 1 | 0.039 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.039 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.038 | Zebrafish | |
| ATXN1L | ataxin 1-like | 0.038 | ||
| JUN | jun proto-oncogene | 0.038 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.037 | ||
| LAMB1 | laminin, beta 1 | 0.037 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.036 | ||
| CTBP1 | C-terminal binding protein 1 | 0.036 | ||
| FLNB | filamin B, beta | 0.036 | ||
| DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.035 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.035 | ||
| BMP4 | bone morphogenetic protein 4 | 0.035 | ||
| EMP1 | epithelial membrane protein 1 | 0.035 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.034 | ||
| EPHA7 | EPH receptor A7 | 0.034 | Human | |
| RHOB | ras homolog gene family, member B | 0.034 | ||
| EGFR | epidermal growth factor receptor | 0.034 | ||
| BMP2 | bone morphogenetic protein 2 | 0.034 | Human | |
| EPHA4 | EPH receptor A4 | 0.034 | Human | |
| APOA1 | apolipoprotein A-I | 0.034 | ||
| SFN | stratifin | 0.033 | ||
| VAV1 | vav 1 guanine nucleotide exchange factor | 0.033 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.033 | ||
| LMNA | lamin A/C | 0.033 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.033 | ||
| PKP3 | plakophilin 3 | 0.032 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.032 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.032 | ||
| TWIST1 | twist homolog 1 (Drosophila) | 0.032 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.032 | ||
| PDE4D | phosphodiesterase 4D, cAMP-specific | 0.031 | ||
| SPOCK1 | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 | 0.031 | ||
| PRR13 | proline rich 13 | 0.031 | ||
| DLL4 | delta-like 4 (Drosophila) | 0.030 | ||
| MCAM | melanoma cell adhesion molecule | 0.030 | ||
| TCEAL5 | transcription elongation factor A (SII)-like 5 | 0.029 | ||
| FOXP3 | forkhead box P3 | 0.029 | ||
| AHNAK | AHNAK nucleoprotein | 0.029 | ||
| NOV | nephroblastoma overexpressed gene | 0.029 | ||
| PCDH17 | protocadherin 17 | 0.029 | ||
| PLXND1 | plexin D1 | 0.029 | ||
| EDN1 | endothelin 1 | 0.029 | ||
| TUBA1A | tubulin, alpha 1a | 0.029 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.029 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.029 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.028 | ||
| S100A10 | S100 calcium binding protein A10 | 0.028 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.028 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.028 | ||
| NID1 | nidogen 1 | 0.028 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.028 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.028 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.027 | ||
| PTRF | polymerase I and transcript release factor | 0.027 | ||
| EFNA5 | ephrin-A5 | 0.027 | Human | |
| NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.027 | ||
| GPR124 | G protein-coupled receptor 124 | 0.027 | Mouse | |
| SFRP2 | secreted frizzled-related protein 2 | 0.027 | ||
| COL4A3BP | collagen, type IV, alpha 3 (Goodpasture antigen) binding protein | 0.027 | ||
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 0.026 | ||
| EHMT2 | euchromatic histone-lysine N-methyltransferase 2 | 0.026 | ||
| MRC2 | mannose receptor, C type 2 | 0.026 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.026 | Human | |
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.026 | ||
| PSEN1 | presenilin 1 | 0.025 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.025 | ||
| IER2 | immediate early response 2 | 0.025 | ||
| VWF | von Willebrand factor | 0.025 | ||
| KDM1A | lysine (K)-specific demethylase 1A | 0.025 | ||
| PRKCQ | protein kinase C, theta | 0.025 | ||
| HDAC5 | histone deacetylase 5 | 0.025 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.024 | ||
| DUSP2 | dual specificity phosphatase 2 | 0.024 | ||
| HAS2 | hyaluronan synthase 2 | 0.024 | ||
| CD3E | CD3e molecule, epsilon (CD3-TCR complex) | 0.024 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.024 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.024 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.024 | ||
| PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.024 | ||
| DLC1 | deleted in liver cancer 1 | 0.024 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.023 | ||
| IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.023 | ||
| UBASH3B | ubiquitin associated and SH3 domain containing B | 0.023 | ||
| JUP | junction plakoglobin | 0.023 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.023 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.023 | ||
| RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.023 | ||
| EPHB2 | EPH receptor B2 | 0.023 | Human | |
| SELE | selectin E | 0.023 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.023 | ||
| PXN | paxillin | 0.022 | ||
| INHBB | inhibin, beta B | 0.022 | ||
| RND3 | Rho family GTPase 3 | 0.022 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.022 | ||
| MYADM | myeloid-associated differentiation marker | 0.022 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.022 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.022 | ||
| INHBA | inhibin, beta A | 0.022 | ||
| FOXF1 | forkhead box F1 | 0.021 | ||
| ITGA6 | integrin, alpha 6 | 0.021 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.021 | ||
| EMCN | endomucin | 0.021 | ||
| EPHB6 | EPH receptor B6 | 0.021 | Human | |
| EPHB4 | EPH receptor B4 | 0.021 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.021 | ||
| VGLL3 | vestigial like 3 (Drosophila) | 0.021 | ||
| NOTCH2NL | notch 2 N-terminal like | 0.021 | ||
| FGF7 | fibroblast growth factor 7 | 0.021 | Human | |
| EPHB1 | EPH receptor B1 | 0.021 | Human | |
| FRS2 | fibroblast growth factor receptor substrate 2 | 0.021 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.020 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.020 | ||
| CD248 | CD248 molecule, endosialin | 0.020 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.020 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.020 | ||
| MMP19 | matrix metallopeptidase 19 | 0.020 | ||
| ITGB4 | integrin, beta 4 | 0.020 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.020 | ||
| MKL2 | MKL/myocardin-like 2 | 0.019 | ||
| EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | 0.019 | ||
| LTBP1 | latent transforming growth factor beta binding protein 1 | 0.019 | ||
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.019 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.019 | ||
| MMRN2 | multimerin 2 | 0.019 | ||
| ANXA1 | annexin A1 | 0.019 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.019 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.019 | ||
| TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.019 | ||
| S100A6 | S100 calcium binding protein A6 | 0.019 | ||
| BMP7 | bone morphogenetic protein 7 | 0.019 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.018 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.018 | ||
| LRRC32 | leucine rich repeat containing 32 | 0.018 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.018 | ||
| AEBP1 | AE binding protein 1 | 0.018 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.018 | Zebrafish | |
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.018 | ||
| TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.018 | ||
| PFDN1 | prefoldin subunit 1 | 0.018 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.018 | ||
| CLDN5 | claudin 5 | 0.018 | ||
| IER3 | immediate early response 3 | 0.018 | ||
| ANXA2 | annexin A2 | 0.018 | ||
| IGFBP7 | insulin-like growth factor binding protein 7 | 0.018 | Zebrafish | |
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.018 | ||
| MYO16 | myosin XVI | 0.017 | ||
| ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | 0.017 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.017 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.017 | ||
| ARL4C | ADP-ribosylation factor-like 4C | 0.017 | ||
| SYN1 | synapsin I | 0.017 | ||
| EFNB3 | ephrin-B3 | 0.017 | Human | |
| MGP | matrix Gla protein | 0.017 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.017 | ||
| COL13A1 | collagen, type XIII, alpha 1 | 0.017 | ||
| THY1 | Thy-1 cell surface antigen | 0.017 | ||
| TAGLN | transgelin | 0.017 | ||
| ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | 0.016 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.016 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.016 | ||
| GAS1 | growth arrest-specific 1 | 0.016 | ||
| ELN | elastin | 0.016 | ||
| OLFML2A | olfactomedin-like 2A | 0.016 | ||
| ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif, 5 | 0.016 | ||
| GATA6 | GATA binding protein 6 | 0.016 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.015 | ||
| BMP1 | bone morphogenetic protein 1 | 0.015 | ||
| RUNX1 | runt-related transcription factor 1 | 0.015 | ||
| MYCT1 | myc target 1 | 0.015 | ||
| ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.015 | ||
| SULF1 | sulfatase 1 | 0.015 | ||
| EXT1 | exostosin 1 | 0.015 | ||
| SEMA3C | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C | 0.015 | ||
| PTPRG | protein tyrosine phosphatase, receptor type, G | 0.015 | ||
| NUMB | numb homolog (Drosophila) | 0.015 | ||
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.015 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.015 | ||
| FAP | fibroblast activation protein, alpha | 0.015 | ||
| KLF7 | Kruppel-like factor 7 (ubiquitous) | 0.015 | Human | |
| BRD4 | bromodomain containing 4 | 0.015 | ||
| FBLN2 | fibulin 2 | 0.015 | ||
| POSTN | periostin, osteoblast specific factor | 0.015 | ||
| LYVE1 | lymphatic vessel endothelial hyaluronan receptor 1 | 0.015 | ||
| PDE4B | phosphodiesterase 4B, cAMP-specific | 0.014 | ||
| S1PR1 | sphingosine-1-phosphate receptor 1 | 0.014 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.014 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.014 | ||
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.014 | ||
| NOG | noggin | 0.014 | ||
| CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.014 | ||
| FOXC1 | forkhead box C1 | 0.014 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.014 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.014 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.014 | ||
| PDIA3 | protein disulfide isomerase family A, member 3 | 0.014 | ||
| NAV3 | neuron navigator 3 | 0.014 | ||
| EPHB3 | EPH receptor B3 | 0.014 | Human | |
| ZNF71 | zinc finger protein 71 | 0.014 | ||
| PLK2 | polo-like kinase 2 | 0.014 | ||
| TCF21 | transcription factor 21 | 0.014 | ||
| LDB2 | LIM domain binding 2 | 0.014 | ||
| MYLK | myosin light chain kinase | 0.014 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.014 | ||
| ADM | adrenomedullin | 0.014 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.014 | ||
| PARVB | parvin, beta | 0.014 | ||
| MYOD1 | myogenic differentiation 1 | 0.014 | ||
| TNXB | tenascin XB | 0.013 | ||
| RSU1 | Ras suppressor protein 1 | 0.013 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.013 | ||
| SGK1 | serum/glucocorticoid regulated kinase 1 | 0.013 | ||
| CD83 | CD83 molecule | 0.013 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.013 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.013 | ||
| OLFML3 | olfactomedin-like 3 | 0.013 | ||
| SNAI2 | snail homolog 2 (Drosophila) | 0.013 | ||
| PLVAP | plasmalemma vesicle associated protein | 0.013 | ||
| CD93 | CD93 molecule | 0.013 | ||
| ZRANB1 | zinc finger, RAN-binding domain containing 1 | 0.013 | ||
| OSMR | oncostatin M receptor | 0.013 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.013 | ||
| PCDH9 | protocadherin 9 | 0.013 | ||
| GPC3 | glypican 3 | 0.013 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.013 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.013 | ||
| ARVCF | armadillo repeat gene deleted in velocardiofacial syndrome | 0.013 | ||
| INSR | insulin receptor | 0.013 | ||
| LAT | linker for activation of T cells | 0.013 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.013 | ||
| LPAR1 | lysophosphatidic acid receptor 1 | 0.013 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.013 | ||
| MAP2 | microtubule-associated protein 2 | 0.013 | ||
| MFAP2 | microfibrillar-associated protein 2 | 0.013 | ||
| MSN | moesin | 0.012 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.012 | ||
| PRSS23 | protease, serine, 23 | 0.012 | ||
| PAX8 | paired box 8 | 0.012 | ||
| IGFBP6 | insulin-like growth factor binding protein 6 | 0.012 | ||
| PODXL | podocalyxin-like | 0.012 | ||
| PCDH7 | protocadherin 7 | 0.012 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.012 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.012 | Human | |
| APOM | apolipoprotein M | 0.012 | ||
| EMILIN1 | elastin microfibril interfacer 1 | 0.012 | ||
| ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | 0.012 | ||
| C1orf54 | chromosome 1 open reading frame 54 | 0.012 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.012 | ||
| EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.012 | ||
| PCDH12 | protocadherin 12 | 0.012 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.012 | ||
| RTN3 | reticulon 3 | 0.012 | ||
| CCDC80 | coiled-coil domain containing 80 | 0.012 | ||
| EPHA2 | EPH receptor A2 | 0.012 | Human | |
| EFNB1 | ephrin-B1 | 0.012 | Human | |
| PTHLH | parathyroid hormone-like hormone | 0.012 | ||
| GATA2 | GATA binding protein 2 | 0.011 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.011 | ||
| IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.011 | ||
| MXRA5 | matrix-remodelling associated 5 | 0.011 | ||
| YWHAB | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide | 0.011 | ||
| BTG2 | BTG family, member 2 | 0.011 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.011 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.011 | ||
| AMOTL2 | angiomotin like 2 | 0.011 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.011 | ||
| CAPN10 | calpain 10 | 0.011 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.011 | ||
| PHLDB1 | pleckstrin homology-like domain, family B, member 1 | 0.011 | ||
| PCOLCE | procollagen C-endopeptidase enhancer | 0.011 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.011 | ||
| ZNF579 | zinc finger protein 579 | 0.011 | ||
| TBL1X | transducin (beta)-like 1X-linked | 0.011 | ||
| JAM2 | junctional adhesion molecule 2 | 0.011 | ||
| DPYSL2 | dihydropyrimidinase-like 2 | 0.011 | ||
| PTGS1 | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | 0.011 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.011 | ||
| GLT8D2 | glycosyltransferase 8 domain containing 2 | 0.011 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.011 | ||
| FBN2 | fibrillin 2 | 0.011 | ||
| ACTN4 | actinin, alpha 4 | 0.011 | ||
| EDNRA | endothelin receptor type A | 0.011 | ||
| MUL1 | mitochondrial E3 ubiquitin protein ligase 1 | 0.011 | ||
| LOXL1 | lysyl oxidase-like 1 | 0.010 | Human | |
| GGA2 | golgi-associated, gamma adaptin ear containing, ARF binding protein 2 | 0.010 | ||
| F2RL3 | coagulation factor II (thrombin) receptor-like 3 | 0.010 | ||
| PTK7 | PTK7 protein tyrosine kinase 7 | 0.010 | ||
| IFNAR1 | interferon (alpha, beta and omega) receptor 1 | 0.010 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.010 | ||
| BCL6B | B-cell CLL/lymphoma 6, member B | 0.010 | ||
| ADAM19 | ADAM metallopeptidase domain 19 | 0.010 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.010 | ||
| FZD2 | frizzled homolog 2 (Drosophila) | 0.010 | ||
| AR | androgen receptor | 0.010 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.010 | ||
| SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | 0.010 | Mouse | |
| SLC2A14 | solute carrier family 2 (facilitated glucose transporter), member 14 | 0.010 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.010 | ||
| MFAP5 | microfibrillar associated protein 5 | 0.010 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.010 | ||
| BMP6 | bone morphogenetic protein 6 | 0.010 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.010 | ||
| DLL3 | delta-like 3 (Drosophila) | 0.010 | Human | |
| PITPNM2 | phosphatidylinositol transfer protein, membrane-associated 2 | 0.010 | ||
| CALD1 | caldesmon 1 | 0.010 |